GLP-1 - The Bright Side

The Bright Side

Sign in Subscribe

GLP-1

A collection of 2 posts

FDA Approves First Oral GLP-1 Pill for Weight Management

Health & Medicine

FDA Approves First Oral GLP-1 Pill for Weight Management

The FDA has approved oral semaglutide (Wegovy) for chronic weight management, marking the first GLP-1 pill available for obesity treatment in the United States. This breakthrough eliminates the need for weekly injections that have been a barrier for many patients considering weight management therapy. The Phase III OASIS 4 trial

GLP-1 medications may protect heart by reopening blocked microvessels

GLP-1 medications may protect heart by reopening blocked microvessels

GLP-1 medications may protect heart by reopening blocked microvessels ## Key Facts Why This Matters This breakthrough represents a significant advancement in its field, offering new possibilities for patients, communities, and research. The implications extend beyond the immediate application, potentially influencing future research directions and treatment approaches. What We Don'